Medical Subject Headings

Last uploaded: November 5, 2019
Preferred Name

Tazobactam

Synonyms

4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S,3S,5R)-

Definitions

A penicillanic acid and sulfone derivative and potent BETA-LACTAMASE inhibitor that enhances the activity of other anti-bacterial agents against beta-lactamase producing bacteria.

ID

http://purl.bioontology.org/ontology/MESH/D000078142

altLabel

4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S,3S,5R)-

YTR830

Tazobactam Sodium

YTR 830H

YTR 830

YTR-830

AQL

AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR

cui

C0149232

C0724700

C0075870

C0149233

DC

1

definition

A penicillanic acid and sulfone derivative and potent BETA-LACTAMASE inhibitor that enhances the activity of other anti-bacterial agents against beta-lactamase producing bacteria.

DX

20190101

HN

2019 (1985)

Inverse of AQ

http://purl.bioontology.org/ontology/MESH/Q000032

http://purl.bioontology.org/ontology/MESH/Q000138

http://purl.bioontology.org/ontology/MESH/Q000737

http://purl.bioontology.org/ontology/MESH/Q000493

http://purl.bioontology.org/ontology/MESH/Q000145

http://purl.bioontology.org/ontology/MESH/Q000506

http://purl.bioontology.org/ontology/MESH/Q000819

http://purl.bioontology.org/ontology/MESH/Q000037

http://purl.bioontology.org/ontology/MESH/Q000134

http://purl.bioontology.org/ontology/MESH/Q000592

http://purl.bioontology.org/ontology/MESH/Q000528

http://purl.bioontology.org/ontology/MESH/Q000008

http://purl.bioontology.org/ontology/MESH/Q000031

http://purl.bioontology.org/ontology/MESH/Q000276

http://purl.bioontology.org/ontology/MESH/Q000191

http://purl.bioontology.org/ontology/MESH/Q000633

http://purl.bioontology.org/ontology/MESH/Q000652

http://purl.bioontology.org/ontology/MESH/Q000009

http://purl.bioontology.org/ontology/MESH/Q000302

http://purl.bioontology.org/ontology/MESH/Q000494

http://purl.bioontology.org/ontology/MESH/Q000266

http://purl.bioontology.org/ontology/MESH/Q000600

http://purl.bioontology.org/ontology/MESH/Q000378

http://purl.bioontology.org/ontology/MESH/Q000097

http://purl.bioontology.org/ontology/MESH/Q000627

Inverse of RB

0

SE10G96M8W

UXA545ABTT

Inverse of SIB

http://purl.bioontology.org/ontology/MESH/D014105

http://purl.bioontology.org/ontology/MESH/D000077613

http://purl.bioontology.org/ontology/MESH/D003622

http://purl.bioontology.org/ontology/MESH/D003619

http://purl.bioontology.org/ontology/MESH/D010664

http://purl.bioontology.org/ontology/MESH/D013449

http://purl.bioontology.org/ontology/MESH/D013453

isa

http://purl.bioontology.org/ontology/MESH/D000900

http://purl.bioontology.org/ontology/MESH/D065093

Machine permutation

2019; TAZOBACTAM was indexed under PENICILLANIC ACIDS 1985-1993; and under PENICILLANIC ACIDS/analogs & derivatives 1994-2018

Mapped from

http://purl.bioontology.org/ontology/MESH/C000594038

MDA

20180709

MMR

20180703

MN

D02.065.589.099.750.687.750

D02.886.108.750.687.750

D02.886.590.841

D03.633.100.300.750.687.750

notation

D000078142

PA

D065093

D000900

prefLabel

Tazobactam

RR

93528-38-2 (Tazobactam)

UXA545ABTT

TERMUI

T157408

T157409

T000942017

T000942018

T157407

TH

FDA SRS (2014)

USP (19XX)

FDA SRS (2013)

NLM (1985)

USAN (19XX)

NLM (2014)

INN (19XX)

tui

T109

T195

T121

subClassOf

http://purl.bioontology.org/ontology/MESH/D010397

http://purl.bioontology.org/ontology/MESH/D013450

Delete Subject Author Type Created
No notes to display